5.5 Medication Reconciliation & Integrating the Medical Record
Key Takeaways
- A brown-bag review — having the patient physically bring every inhaler, tablet, eye drop, supplement, and cream to the visit — surfaces duplications, expired devices, and hidden beta-blockers that a verbal medication list reliably misses.
- The Asthma Medication Ratio divides controller fills by total asthma medication fills; a ratio below 0.50 flags reliever-dominant, under-controlled asthma and is the basis of the NCQA HEDIS quality measure.
- Dose counters and pharmacy refill dates give objective adherence data that patient self-report consistently overstates.
- Topical ophthalmic beta-blockers, over-the-counter NSAIDs, and herbal products are the three categories patients most often omit when asked to list their medications, and each can precipitate bronchospasm.
- Chart integration means reconciling five streams — prior spirometry, exacerbation and admission history, oral corticosteroid bursts, prescription fill records, and specialist notes — before designing any education plan.
5.5 Medication Reconciliation & Integrating the Medical Record
Quick Answer: Ask patients to bring every product they put in or on their body — inhalers, tablets, eye drops, nasal sprays, creams, supplements, and teas — rather than reciting a list. Then reconcile that physical inventory against pharmacy fill records, dose counters, and the chart. The single most useful objective adherence metric is the Asthma Medication Ratio (AMR): controller fills divided by total asthma medication fills, where below 0.50 signals reliever-dominant, poorly controlled asthma.
Two Detailed Content Outline tasks sit behind this section: soliciting information about medications, alternative and complementary therapies, and over-the-counter products; and integrating information from the medical record into the assessment. Both are routinely skipped, and both routinely change the plan.
The Brown-Bag Review
Verbal medication lists fail predictably. Patients recite what they were prescribed, not what they take; they omit anything they do not classify as medication; and they cannot name devices they use daily.
Protocol:
- At scheduling, instruct the patient to bring every container — prescription bottles, all inhalers and spacers, eye drops, nasal sprays, topical creams, vitamins, herbal products, and any teas or remedies used for breathing.
- Lay the products out. Ask about each one: "Tell me how you actually use this one." Never ask "Do you take this as prescribed?", which invites a socially desirable answer.
- Check the dose counter on every inhaler and the expiration date on every device.
- Ask separately about the three categories patients systematically omit.
| Commonly omitted category | Why it is omitted | Asthma consequence |
|---|---|---|
| Ophthalmic beta-blockers (timolol, levobunolol) | Patients do not classify eye drops as systemic medication | Non-selective beta-blockade absorbed through the nasolacrimal duct, bypassing first-pass metabolism; can precipitate refractory bronchospasm |
| Over-the-counter NSAIDs and hidden combination products | Considered "not real medicine"; aspirin and ibuprofen are buried in cold, sinus, and menstrual remedies | Life-threatening reactions in aspirin-exacerbated respiratory disease |
| Herbal, nutritional, and complementary products | Assumed harmless or feared to invite judgment | Unknown potency and contaminants; some interact with theophylline or corticosteroids; delay of effective therapy |
Non-judgmental phrasing that works: "Most people miss doses — in the last week, how many days do you think you missed your controller?" Normalizing the behavior before asking the number produces a materially more honest answer than a yes/no adherence question.
Objective Adherence Data
Self-reported adherence overstates actual use consistently. Four objective sources close the gap.
| Source | What it shows | Limitation |
|---|---|---|
| Pharmacy refill records | Whether medication was ever dispensed and how often | Dispensing is not ingestion or inhalation |
| Dose counters | Actuations remaining versus expected | Absent on some older devices; can be defeated by shaking or test-firing |
| Canister count over time | SABA canisters per year is the classic risk marker | Requires accurate fill history |
| Electronic inhaler monitors | Timestamped actuation data | Cost and availability limit routine use |
The Asthma Medication Ratio (AMR)
- AMR of 0.50 or above is the threshold used by the NCQA HEDIS Asthma Medication Ratio quality measure and is associated with fewer emergency department visits and hospitalizations.
- AMR below 0.50 means the patient's asthma pharmacy footprint is dominated by rescue medication — the pharmacologic signature of uncontrolled disease regardless of what the patient reports.
Worked example. Over 12 months a patient filled 2 ICS-LABA inhalers and 7 albuterol inhalers. AMR = 2 ÷ (2 + 7) = 0.22. Well below 0.50, and the 7 SABA canisters independently exceed the ≥3 canisters-per-year threshold for elevated exacerbation and asthma-death risk. Two independent signals point at the same conclusion before the patient has said a word about symptoms.
Exam Trap: A high AMR does not prove good technique. A patient may fill controller medication faithfully and still deposit almost none of it in the lungs. Refill data answers "is the medication in the house?"; return demonstration answers "is the medication in the lungs?" Both are required.
Integrating the Medical Record
The Detailed Content Outline lists the chart elements explicitly: family, clinical, and past medical history; physical examination; vital sign findings; laboratory, pulmonary function, and radiological results; current and past therapies; and diagnostic interpretations of objective measures. In practice, five streams change the education plan before it is drafted.
| Chart stream | What to extract | How it changes the plan |
|---|---|---|
| Prior spirometry and PEF | Best-ever FEV1 and personal best PEF; trend across years | Establishes the achievable target and whether fixed obstruction has developed; prevents building action-plan zones on an artificially low "personal best" recorded during a flare |
| Exacerbation and utilization history | Emergency visits, admissions, ICU stays, any intubation | Any prior intubation or ICU admission permanently classifies the patient as high-risk and mandates a written action plan plus close follow-up |
| Oral corticosteroid bursts | Number of courses in the past 12 months | Two or more bursts per year signals inadequate controller therapy and independently predicts future exacerbations |
| Prescription fill history | AMR, SABA canisters per year, gaps in controller supply | Distinguishes a therapy problem from an adherence problem from an access problem |
| Specialist and allergy results | Skin prick or specific IgE results, FeNO, eosinophil counts, prior consultations | Determines which allergens actually warrant environmental remediation — remediating a non-sensitized allergen wastes limited household money |
The Reconciliation Sequence
1. Brown-bag inventory ─► what the patient physically possesses
│
2. Fill history / AMR ─► what the pharmacy actually dispensed
│
3. Dose counters ─► what was actuated
│
4. Chart review ─► what was prescribed, and what happened clinically
│
▼
Discrepancies drive the education plan:
• Possesses but does not fill ─► cost, access, or transportation barrier
• Fills but does not actuate ─► belief, forgetfulness, or steroid phobia
• Actuates but no clinical benefit ─► device technique failure or wrong diagnosis
• Possesses a contraindicated drug ─► immediate safety escalation to the prescriber
Scope reminder: The asthma educator reconciles, documents, and reports. Discovering that a patient with asthma is using timolol eye drops or a non-selective oral beta-blocker calls for prompt communication with the prescribing clinician — the educator does not discontinue, substitute, or adjust prescribed therapy independently.
Over 12 months a patient filled 2 ICS-LABA inhalers and 7 albuterol inhalers. What is the Asthma Medication Ratio, and what does it indicate?
Which medication category do patients most often omit from a verbal medication list despite its potential to precipitate refractory bronchospasm?
A patient has an Asthma Medication Ratio of 0.75 but remains symptomatic daily. What does the ratio establish, and what does it leave unanswered?